Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.

de Almeida Chuffa LG, de Moura Ferreira G, Lupi LA, da Silva Nunes I, Fávaro WJ.

J Ovarian Res. 2018 Jan 17;11(1):8. doi: 10.1186/s13048-018-0380-5.

2.
3.

Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.

Garcia PV, Seiva FR, Carniato AP, de Mello Júnior W, Duran N, Macedo AM, de Oliveira AG, Romih R, Nunes Ida S, Nunes Oda S, Fávaro WJ.

BMC Cancer. 2016 Jul 7;16:422. doi: 10.1186/s12885-016-2474-z.

4.

Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.

Garcia PV, Apolinário LM, Böckelmann PK, da Silva Nunes I, Duran N, Fávaro WJ.

Int J Clin Exp Pathol. 2015 May 1;8(5):4427-43. eCollection 2015.

5.

Effects of P-MAPA immunomodulator on Toll-like receptor 2, ROS, nitric oxide, MAPKp38 and IKK in PBMC and macrophages from dogs with visceral leishmaniasis.

Melo LM, Perosso J, Almeida BF, Silva KL, Somenzari MA, de Lima VM.

Int Immunopharmacol. 2014 Feb;18(2):373-8. doi: 10.1016/j.intimp.2013.12.012. Epub 2013 Dec 24.

PMID:
24374021
6.

Improvement in clinical signs and cellular immunity of dogs with visceral leishmaniasis using the immunomodulator P-MAPA.

Santiago ME, Neto LS, Alexandre EC, Munari DP, Andrade MM, Somenzari MA, Ciarlini PC, de Lima VM.

Acta Trop. 2013 Sep;127(3):174-80. doi: 10.1016/j.actatropica.2013.04.005. Epub 2013 Apr 29.

7.

Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer.

Fávaro WJ, Nunes OS, Seiva FR, Nunes IS, Woolhiser LK, Durán N, Lenaerts AJ.

Infect Agent Cancer. 2012 Jun 18;7(1):14. doi: 10.1186/1750-9378-7-14.

8.

A biotechnological product and its potential as a new immunomodulator for treatment of animal phlebovirus infection: Punta Toro virus.

Durán N, Gowen BB, Costa FT, Justo GZ, Brocchi M, Nunes OS, Nunes IS.

Antiviral Res. 2009 Aug;83(2):143-7. doi: 10.1016/j.antiviral.2009.04.006. Epub 2009 Apr 22.

PMID:
19393266

Supplemental Content

Loading ...
Support Center